Clinical Trial Update: Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab in combination with chemotherapy as neoadjuvant treatment for inflammatory breast cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-02-25